|
Volumn 179, Issue , 2015, Pages 329-330
|
Neprilysin inhibitors preserve renal function in heart failure
|
Author keywords
Heart failure; Neprilysin inhibitors; Renal dysfunction
|
Indexed keywords
3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONIC ACID PLUS VALSARTAN;
CREATININE;
ENALAPRIL;
ENKEPHALINASE INHIBITOR;
LISINOPRIL;
MEMBRANE METALLOENDOPEPTIDASE;
OMAPATRILAT;
VALSARTAN;
AMINOBUTYRATES;
LCZ 696;
NEPRILYSIN;
TETRAZOLES;
ARTICLE;
CARDIOVASCULAR MORTALITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ENZYME INHIBITION;
GLOMERULUS FILTRATION RATE;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
HYPERTENSION;
HYPERVOLEMIA;
ISCHEMIC CARDIOMYOPATHY;
KIDNEY FUNCTION;
META ANALYSIS (TOPIC);
NEW YORK HEART ASSOCIATION CLASS;
NONHUMAN;
OUTCOME ASSESSMENT;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK REDUCTION;
SODIUM EXCRETION;
SODIUM RETENTION;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
ENZYMOLOGY;
HUMANS;
KIDNEY;
META ANALYSIS;
METABOLISM;
METHODS;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
AMINOBUTYRATES;
HEART FAILURE;
HUMANS;
KIDNEY;
NEPRILYSIN;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TETRAZOLES;
|
EID: 84920692516
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2014.11.059 Document Type: Article |
Times cited : (31)
|
References (10)
|